Dal-Hee Min

Dal-Hee Min

Company: Seoul National University

Job title: CTO & Co-Founder, Lemonex Inc. & Professor


DegradaBALL-siRNA Complex (LEM-S401) for Effective Local Administration to Treat Skin Fibrosist 4:00 pm

New concept of DDS, DegradaBALL, was employed for siRNA therapeutics against skin fibrosis (LEM-S401) Local injection of LEM-S401 showed highly effective and sustainable knockdown efficiency at the injection site Local injection of the DegradaBALL-RNA complex would be well-suited for extrahepatic delivery by minimizing liver accumulationRead more

day: Track B Day 1 PM

Panel Discussion – From Theory to Reality: Targeting Cancer with siRNA Therapeutics 2:00 pm

In the past year, siRNA therapeutics have rocketed as a widely promising potential therapy for several diseases. With the major shift of interest in oncology, it is critical to now consider the viability of targeting the tumors for therapeutic intervention & debate the important next steps to ensure siRNA cancer drugs become a reality Addressing…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.